October 27, 2020
FDA drafting protocols to track COVID-19 vaccine safety
Editor's Note
The Food and Drug Administration’s (FDA’s) Office of Biostatistics and Epidemiology is currently developing master protocols to be used in monitoring the safety and effectiveness of a COVID-19 vaccine once it is authorized or approved, in addition to postmarket surveillance requirements, the October 22 Regulatory Focus reports.
The FDA will draw on big data resources and the Centers for Disease Control and Prevention to follow the vaccines’ track records.
The protocols will be posted for public comment.
Free Daily News
- Neurosurgery trial: Early evacuation improves long-term hemorrhage outcomes
- Drug shortages higher than ever
- FDA announces class 1 recalls for premixed embolic, infusion pump software
- Academic medical centers identify performance-improvement priorities
- Propofol anesthesia for colonoscopy could help find polyps, prevent cancer
- FDA Class 1 recall renews concern about historically problematic heart pumps
- New physician compensation report reveals modest pay gains but growing discontent with the profession
- Surge in corporate ownership of medical practices raises concerns over physician autonomy, care quality
- How Minneapolis healthcare real estate remained strong amid challenges, shifts in patient care preferences: Lessons for other states
- Artificial intelligence (AI) captures uncertainty in medical scans
© Access Intelligence, LLC. All rights reserved. | Privacy Policy | Diversity, Equity, Inclusion & Belonging